Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PEPD | P12955 | 1/20 | 0.57 |
| ▸ | IDO1 | P14902 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | KIF11 | P52732 | 4/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | GFER | P55789 | 1/20 | 0.52 |
| ▸ | FPR2 | P25090 | 3/20 | 0.51 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28296509 | 0.83 | PEPD (0.61) | PEPDALDH1A1LMNANPC1MAPT | |
| SCHEMBL5062623 | 0.82 | PEPD (0.80) | PEPDALDH1A1LMNANPC1MAPT | |
| SCHEMBL3074944 | 0.81 | ALDH1A1 (0.70) | IDO1ALDH1A1LMNANOX1NPC1 | |
| SCHEMBL836968 | 0.81 | ALDH1A1 (0.62) | IDO1ALDH1A1LMNANOX1NPC1 | |
| SCHEMBL27644436 | 0.81 | ALDH1A1 (0.58) | IDO1ALDH1A1LMNANOX1NPC1 | |
| Acetic Acid SCHEMBL27571220 | 0.80 | ALDH1A1 (0.53) | IDO1ALDH1A1LMNANOX1NPC1 | |
| SCHEMBL5521712 | 0.79 | IDO1 (0.67) | IDO1ALDH1A1LMNANOX1NPC1 | |
| SCHEMBL6624525 | 0.79 | IDO1 (0.56) | IDO1ALDH1A1LMNANOX1NPC1 | |
| SCHEMBL6390723 | 0.79 | CA1 (0.54) | IDO1ALDH1A1LMNANOX1NPC1 | |
| SCHEMBL5169940 | 0.78 | IDO1 (0.56) | IDO1ALDH1A1LMNANOX1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117479943-A | EGFR inhibitors and PERK activators in combination therapies and use thereof for treating cancer | 基因泰克公司 | 2024-01-30 | — | — | CN | claimed |
| CN-111988996-A | Increasing yield of nut bearing plants | UPL有限责任公司 | 2020-11-24 | — | — | CN | claimed |
| US-20190254281-A1 | ENHANCED YIELD IN NUT BEARING PLANTS | UPL CORPORATION LTD. (MU) | 2019-08-22 | — | — | US | claimed |
| WO-2019161274-A1 | ENHANCED YIELD IN NUT BEARING PLANTS | UPL CORPORATION LTD. (MU) | 2019-08-22 | — | — | WO | claimed |
| WO-2001064036-A1 | ENHANCEMENT OF SEED/FRUIT/NUT YIELDS FROM FLOWERING PLANTS | UNIROYAL CHEMICAL COMPANY, INC. (US) | 2001-09-07 | — | — | WO | claimed |
| US-6242385-B1 | SEEDS OF LEGUME PLANTS, APPLYING TO FOLAGE DURING REPRODUCTION PHENYLUREA DERIVATIVES | UNIROYAL CHEMICAL COMPANY, INC. | 2001-06-05 | — | — | US | claimed |
| CN-117479943-A | EGFR inhibitors and PERK activators in combination therapies and use thereof for treating cancer | 基因泰克公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-111988996-B | Improving yield of nut bearing plants | UPL有限责任公司 | 2023-07-14 | — | — | CN | disclosed |
| US-11641859-B2 | Enhanced yield in nut bearing plants | UPL CORPORATION LTD. (MU) | 2023-05-09 | — | — | US | disclosed |
| CN-111988996-A | Increasing yield of nut bearing plants | UPL有限责任公司 | 2020-11-24 | — | — | CN | disclosed |
| US-20190254281-A1 | ENHANCED YIELD IN NUT BEARING PLANTS | UPL CORPORATION LTD. (MU) | 2019-08-22 | — | — | US | disclosed |
| WO-2019161274-A1 | ENHANCED YIELD IN NUT BEARING PLANTS | UPL CORPORATION LTD. (MU) | 2019-08-22 | — | — | WO | disclosed |
| US-8809367-B2 | 1-1-Oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators | ALLERGAN, INC. (US) | 2014-08-19 | — | — | US | disclosed |
| US-20050267145-A1 | Treatment for lung cancer | COLEY PHARMACEUTICAL GROUP, INC. | 2005-12-01 | — | — | US | disclosed |
| US-20050197350-A1 | Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof | TAISHO PHARMACEUTICAL CO., LTD. | 2005-09-08 | — | — | US | disclosed |
| WO-2005063763-A1 | NOVEL FUSED PYRROLOCARBAZOLES | CEPHALON, INC. (US) | 2005-07-14 | — | — | WO | disclosed |
| CN-1443179-A | Aniline derivatives | HOFFMANN LA ROCHE (CH) | 2003-09-17 | — | — | CN | disclosed |
| WO-2001064036-A1 | ENHANCEMENT OF SEED/FRUIT/NUT YIELDS FROM FLOWERING PLANTS | UNIROYAL CHEMICAL COMPANY, INC. (US) | 2001-09-07 | — | — | WO | disclosed |
| US-6242385-B1 | SEEDS OF LEGUME PLANTS, APPLYING TO FOLAGE DURING REPRODUCTION PHENYLUREA DERIVATIVES | UNIROYAL CHEMICAL COMPANY, INC. | 2001-06-05 | — | — | US | disclosed |
| US-5441984-A | Antidiabetic agent | ELI LILLY AND COMPANY (US) | 1995-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190254281-A1 | ENHANCED YIELD IN NUT BEARING PLANTS | NUTF2, MYCBP, MYCBP2 | PEPD 3259/4885IDO1 2115/4885ALDH1A1 3840/4885 |
| US-11641859-B2 | Enhanced yield in nut bearing plants | NUTF2, MYCBP, MYCBP2 | PEPD 3259/4885IDO1 2115/4885ALDH1A1 3840/4885 |
| US-20050197350-A1 | Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof | HCRTR2, MCHR1, MCHR2 | PEPD 1416/4885IDO1 289/4885ALDH1A1 2036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.